参考文献/References:
[1] Jemal A,Siegel R,Xu JQ,et al.Cancer statistics,2010.CA Cancer J Clin,2010,60(5):277-300.
[2] Solbiati L,Cioffi V,Ballarati E.Uhrasonography of the neck.Radiol Clin North Am,1992,30(5):941-954.
[3] 陈晓辉,柳硕岩,吴周贵.彩超检查对食管癌颈部淋巴结转移的诊断价值(附150例分析).福建医药杂志,2009,31(3):108-110.
[4] 于海容,朱强,乔华.超声对头颈部恶性肿瘤颈部淋巴结转移的诊断价值.山东医药,2009,49(48):77-79
[5] Rubaltelli L,Corradin S,Dorigo A,et al.Automated quantitative evaluation of lymph node perfusion on contrast-enhanced sonography.AJR Am J Roentgenol,2007,188(4):977-983.
[6] Valls C,Andia E,Sanchez A,et al.Dual-phase helical CT of pancreatic adenocarcinoma:assessment of resectability before surgery.AJR Am J Roentgenol,2002,178(4):821-826.
[7] 陆秀伟,谢筱唏,徐莉萍,等.胆囊癌淋巴结转移的多层螺旋CT分析.实用放射学杂志,2010,26(9):1295-1297.
[8] 乔英,李健丁,张瑞平,等.CT三期增强扫描对胃癌淋巴结转移的诊断价值.放射学实践,2006,21(5):507-510.
[9] Rumboldt Z,Al-Okaili R,Deveikis JP.Perfusion CT for head and neck tumors:pilot study.AJNR Am J Neuroradiol,2005,26(5):1178-1185.
[10] de Bondt RB,Hoeberigs MC,Nelemans PJ,et al.Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma.Neuroradiology,2009,51(3):183-192.
[11] Eiber M,Beer AJ,Holzapfel K,et al.Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging.Invest Radiol,2010,45(1):15-23.
[12] Nakai G,Matsuki M,Inada Y,et al.Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imaging.J Comput Assist Tomogr,2008,32(5):764-768.
[13] Kwee TC,Takabara T,Luijten PR,et al.ADC measurements of lymph nodes:inter-and intra-observer reproducibility study and all overview of the literature.Eur J Radiol,2010,75(2):215-220.
[14] Saokar A,Braschi M,Harisinghani M.Lymphotrophic nanoparticle enhanced MR imaging (LNMRI) for lymph node imaging.Abdom Imaging,2006,31(6):660-667.
[15] Harisinghani MG,Saini S,Weissleder R,et al.MR lymphangiography using uhrasmall super paramagnetic iron oxide in patients with primary abdominal and pelvic malignancies:radiographic-pathologic correlation.AJR Am J Roentgenol,1999,172(5):1347-1351.
[16] 吴元魁,许乙凯,黄其鎏.超顺磁氧化铁粒子增强MRI区分肿瘤转移性与良性淋巴结的实验研究.中华放射学杂志,2002,36(6):562-566.
[17] Pandharipande PV,Mora JT,Uppot RN,et al.Lymphotropie nanoparticle-enhaneed MRI for independent prediction of lymph node malignancy:a logistic regression model.AJR Am J Roentgenol,2009,193(3):W230-W237.
[18] Will O,Purkayastha S,Chan C,et al.Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases:a meta-analysis.Lancet Oncol,2006,7(1):52-60.
[19] Thoeny HC,Triantafyllou M,Birkhaeuser FD,et al.Combined uhrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients.Eur Urol,2009,55(4):761-769.
[20] Fletcher JW,Djulbegovie B,Soares HP,et al.Recommendations on the use of 18F-FDG PET in oncology.J Nucl Med,2008,49(3):480-508.
[21] Kyzas PA,Evangelou E,Denaxa-Kyza D,et al.18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma:a meta-analysis.J Nail Cancer Inst,2008,100(10):712-720.
[22] Gould MK,Kuschner WG,Rydzak CE,et al.Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer:a meta-analysis.Ann Intern Med,2003,139(11):879-892.
[23] Basu S,Kung J,Houseni M,et al.Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma:implications for its utilization in assessing malignant lesions.Q J Nucl Med Mol Imaging,2009,53(1):9-19.
[24] Kwee TC,Basu S,Torigian DA,et al.Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer:evolving contribution of PET in this setting.Eur J Nucl Med Mol Imaging,2011,38(7):1353-1366.
[25] Jeong HS,Back CH,Son YI,et al.Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma.Head Neck,2007,29(3):203-210.
相似文献/References:
[1]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[2]张胤,陈跃.18F-氟化钠PET/CT诊断肿瘤骨转移应用进展[J].国际放射医学核医学杂志,2015,39(1):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
Zhang Yin,Chen Yue.Application progress of 18F-NaF PET/CT in the diagnosis of neoplasm metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
[3]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
[4]刘雪辉,李洪均,于鸿煦.SPECT/CT融合显像对可疑骨转移灶的诊断效能[J].国际放射医学核医学杂志,2015,39(3):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
Liu Xuehui,Li Hongjun,Yu Hongxu.Diagnostic efficacy of SPECT/CT fusion imaging in assessing possible bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
[5]桂继琮,刘兴党.镭-223氯化物治疗去势抵抗性前列腺癌骨转移的研究进展[J].国际放射医学核医学杂志,2015,39(3):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
Gui Jicong,Liu Xingdang.Development in the study of radium-223 chloride for treating castration-resistant prostate carcinoma with bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
[6]高平,王茜,赵赟赟,等.99Tcm-MDP SPECT/CT显像用于骨肉瘤肺转移的诊断[J].国际放射医学核医学杂志,2014,38(3):148.[doi:10.3760/cma.j.issn.1673-4114.2014.03.002]
Gao Ping,Wang Qian,Zhao Yunyun,et al.99Tcm-MDP SPECT/CT used in diagnosis of pulmonary metastasis from osteosarcoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):148.[doi:10.3760/cma.j.issn.1673-4114.2014.03.002]
[7]凌彩霞,肖国有.SPECT/CT骨断层显像及在恶性肿瘤骨转移诊断中的临床价值[J].国际放射医学核医学杂志,2014,38(4):275.[doi:10.3760/cma.j.issn.1673-4114.2014.04.016]
Ling Caixia,Xiao Guoyou.The clinical value of SPECT/CT bone tomography in the diagnosis of malignant tumor metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):275.[doi:10.3760/cma.j.issn.1673-4114.2014.04.016]
[8]刘超,邓智勇,刘鹏杰,等.89SrCL2与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析[J].国际放射医学核医学杂志,2014,38(5):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
Liu Chao,Deng Zhi-yong,Liu Peng-jie,et al.Analysis on the curative effect of combination therapy with zoledronic acid and 89SrCL2 on bone tumor with breast cancer metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
[9]王宇峰,刘海娜,张居洋,等.SPECT/CT融合显像对乳腺癌骨转移的诊断价值[J].国际放射医学核医学杂志,2014,38(6):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
Wang Yu-feng,Liu Hai-na,Zhang Ju-yang,et al.Clinical value of SPECT/CT fusion imaging in diagnosing metastatic bone lesions in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
[10]赵红光,徐松柏,关锋,等.骶骨脊索瘤伴肺转移18F-FDG PET/CT显像一例[J].国际放射医学核医学杂志,2013,37(2):128.[doi:10.3760/cma.j.issn.1673-4114.2013.02.017]
[11]刘长江,董燕玉.99Tcm-depreotide显像对肺部病灶的鉴别诊断价值[J].国际放射医学核医学杂志,2009,33(2):79.[doi:10.3760/cma.j.issn.1673-4114.2009.02.005]
LIU Chang-fiang,DONG Yan-yu.The clinical value of 99Tcm-depreotide scintigraphy in differentiating malignant from benign lesions in the lung[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(6):79.[doi:10.3760/cma.j.issn.1673-4114.2009.02.005]